Search research articles
Contact Us
Filters
Showing results (81-90 of 135) with videos related to
Page
of 14
Sort By:
Expert Review of Anti-Infective Therapy
|
November 18, 2022
Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature
Santiago Grau, Jose Maria Miró, Julian Olalla, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
January 25, 2017
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer
Dolores Isla, Javier De Castro, Oscar Juan, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
August 16, 2019
Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain
Laura Sánchez-Cenizo, Javier Aller, José Manuel Martínez-Sesmero, et al.
Journal of Materials Science. Materials in Medicine
|
July 4, 2007
Determination of metallic traces in kidneys, livers, lungs and spleens of rats with metallic implants after a long implantation time
Juan Carlos Rubio, Maria Cristina Garcia-Alonso, Concepcion Alonso, et al.
Archives of Neurology
|
September 12, 2012
MPV17 Mutations Causing Adult-Onset Multisystemic Disorder With Multiple Mitochondrial DNA Deletions
Caterina Garone, Juan Carlos Rubio, Sarah E Calvo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
February 5, 2015
A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain
Josep Comín-Colet, Darío Rubio-Rodríguez, Carlos Rubio-Terrés, et al.
Archivos Espanoles De Urologia
|
March 13, 2023
Economic Impact Associated with Patients with Overactive Bladder on Drug Treatment with Mirabegron or Antimuscarinics in Spain
Aurora Ortiz Núñez, Rodrigo Martins de Almeida, Laura Mateu Arrom, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
October 6, 2016
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Luis Felipe Casado, Amparo Burgos, Eva González-Haba, et al.
Revista Espanola De Salud Publica
|
January 18, 2013
[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement]
Inmaculada Gómez Arrayas, Carmen Suárez Fernández, Jorge F Gómez Cerezo, et al.
Research in Developmental Disabilities
|
September 11, 2016
Benefits of an experimental program of equestrian therapy for children with ADHD
Andrés García-Gómez, Marta Rodríguez-Jiménez, Eloísa Guerrero-Barona, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 135) with videos related to
Sort By:
Page
of 14
Expert Review of Anti-Infective Therapy
|
November 18, 2022
Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature
Santiago Grau, Jose Maria Miró, Julian Olalla, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
January 25, 2017
Costs of adverse events associated with erlotinib or afatinib in first-line treatment of advanced EGFR-positive non-small cell lung cancer
Dolores Isla, Javier De Castro, Oscar Juan, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
August 16, 2019
Burden of diabetes mellitus in patients with acromegaly treated with second-line pharmacotherapy in Spain
Laura Sánchez-Cenizo, Javier Aller, José Manuel Martínez-Sesmero, et al.
Journal of Materials Science. Materials in Medicine
|
July 4, 2007
Determination of metallic traces in kidneys, livers, lungs and spleens of rats with metallic implants after a long implantation time
Juan Carlos Rubio, Maria Cristina Garcia-Alonso, Concepcion Alonso, et al.
Archives of Neurology
|
September 12, 2012
MPV17 Mutations Causing Adult-Onset Multisystemic Disorder With Multiple Mitochondrial DNA Deletions
Caterina Garone, Juan Carlos Rubio, Sarah E Calvo, et al.
Revista Espanola De Cardiologia (English Ed.)
|
February 5, 2015
A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain
Josep Comín-Colet, Darío Rubio-Rodríguez, Carlos Rubio-Terrés, et al.
Archivos Espanoles De Urologia
|
March 13, 2023
Economic Impact Associated with Patients with Overactive Bladder on Drug Treatment with Mirabegron or Antimuscarinics in Spain
Aurora Ortiz Núñez, Rodrigo Martins de Almeida, Laura Mateu Arrom, et al.
Clinicoeconomics and Outcomes Research : CEOR
|
October 6, 2016
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain
Luis Felipe Casado, Amparo Burgos, Eva González-Haba, et al.
Revista Espanola De Salud Publica
|
January 18, 2013
[Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement]
Inmaculada Gómez Arrayas, Carmen Suárez Fernández, Jorge F Gómez Cerezo, et al.
Research in Developmental Disabilities
|
September 11, 2016
Benefits of an experimental program of equestrian therapy for children with ADHD
Andrés García-Gómez, Marta Rodríguez-Jiménez, Eloísa Guerrero-Barona, et al.
Page
of 14